- Investor call and webcast scheduled for Monday, November 14 at 8:00 am EST
- Roivant will present at investor conferences in November
BASEL, Switzerland and LONDON and NEW YORK and BOSTON, Oct. 18, 2022 (GLOBE NEWSWIRE) — Roivant Sciences ROIV announced today that it will host a live conference call and webcast on Monday, November 14, 2022 at 8:00 a.m. EST to present its financial results for the second quarter ended September 30, 2022 and to provide a company update .
For telephone access to the conference call, please register online here registration link. A webcast of the conference call will also be available under Events & Presentations on the Investors section of the Roivant website at https://investor.roivant.com/news-events/events. The archived webcast will be available on Roivant’s website after the call.
In addition, Roivant will be attending three upcoming investor conferences:
- Credit Suisse 31St Annual Health Conference in Rancho Palos Verdes, CA November 7-10. CFO Richard Pulik will present on Tuesday, November 8 at 7:25 p.m. EST (4:25 p.m. PST).
- Jefferies 2022 London Healthcare Conference, November 15-17 in London. CEO Matt Gline will present on Tuesday, November 15 at 10:15am EST (3:15pm GMT).
- The Evercore ISI HealthCONx conference, taking place virtually from November 29th to December 1st. CEO Matt Gline will present on Wednesday, November 30th at 4:20pm EST.
A live webcast of each presentation will be available under Events & Presentations on the Investors section of the Roivant website athttps://investor.roivant.com/news-events/eventsand an archived recording will be available after the presentation.
About Roivant Sciences
Roivant’s mission is to improve patient healthcare by turning every inefficiency into an opportunity. Roivant develops transformative medicines faster by developing technology and developing talent in creative ways, leveraging the Roivant platform to bring “Vants” to market – agile and…
